Support our sponsors:

NZX 50 Index	4611.96	2.40
S&P/ASX 200	5191.20	0.00
Dow Jones Industrials	14839.80	21.00

Twitter

Facebook

RSS

Daily ShareChat: Ryman Healthcare

By Jenny Ruth

Thursday 26th May 2011

Text too small?

Ryman Healthcare's better-than-expected 17% rise in underlying profit for the year ended March reaffirms the company's investment attractions, says David Oxley at Craigs Investment Partners.

"Our model suggests that as the existing portfolio matures, even relatively conservative asset price inflation assumptions result in attractive rates of growth in underlying profit and operating cashflow and a DCF(discounted cashflow)-derived intrinsic value estimate above the current share price," Oxley says. He values the shares at $2.95.

Ryman's $72.1 million reported net underlying profit ($100 million including capital gains) compared with Oxley's $71.5 million forecast.

"While sales of existing units were marginally below our estimates, new unit sales were ahead of expectations and development margins were maintained above 20%."

Oxley has raised his forecasts for Ryman to reflect both the strong result and management's decision to up its build rate from 450 beds a year to 550 beds.

He is forecasting net profit including capital gains in the year ending March 2012 will be $108 million, rising to $122 million the following year and to $129 million in the year ending March 2014. "The key risk to our forecast is the underlying asset price inflation assumed. Our base case is 3% per annum nominal growth throughout the forecast period."

Recommendation: Buy.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.